1397 CDR404, an antibody-based bispecific & bivalent T-cell engager targeted against MAGE-A4, for Squamous Non-Small Cell Lung Cancer (SQ-NSCLC)

Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
DOI: 10.1136/jitc-2023-sitc2023.1397 Publication Date: 2023-10-31T14:50:25Z